Revolutionary immunotherapies such as Chimeric Antigen Receptor (CAR) T-cell therapy and T-cell engaging bispecific antibodies (BsAbs) have fundamentally altered the therapeutic landscape for haematological malignancies, including myeloma, leukaemia, and lymphoma.…
Chimeric antigen receptor T-cell (CAR T) therapy stands as one of the most remarkable breakthroughs in modern oncology. By genetically reprogramming a patient’s own immune cells to selectively target, bind…
Executive Overview Cutaneous T-cell lymphomas (CTCLs) represent a complex and heterogeneous family of clonal lymphoproliferative disorders originating from skin-homing T cells. While indolent variants such as early-stage mycosis fungoides often…
Executive Overview Acute lymphoblastic leukemia (ALL) remains the most prevalent pediatric malignancy globally, yet a profound geopolitical divide continues to dictate survival outcomes. While high-income countries routinely achieve long-term pediatric…
Executive Overview Acute promyelocytic leukemia (APL) has long been considered one of the great success stories of modern hematology, with standard-risk patients routinely achieving cure rates exceeding 90% via targeted…
Executive Overview For more than half a century, cytotoxic chemotherapy has achieved a monumental milestone in modern medicine: the routine, durable cure of a select group of aggressive malignancies. While…
Executive Overview For decades, disease relapse following an allogeneic hematopoietic cell transplantation (allo-HCT)—the high-stakes curative procedure for acute leukemias and myelodysplastic syndromes (MDS)—has represented one of the most disheartening outcomes…
Executive Overview When a patient receives a leukaemia diagnosis, the shockwaves instantly reverberate far beyond hospital walls, profoundly altering the lives of partners, parents, children, and close friends who step…
In a rare and clinically complex case highlighting the hidden dangers of cancer-associated coagulopathy, medical specialists at Padua University Hospital in Italy successfully diagnosed and treated a 21-year-old woman who…
Executive Overview Acute Myeloid Leukemia (AML) is one of the most aggressive and complex malignancies of the human hematopoietic system. Characterized by the uncontrolled clonal expansion of immature myeloid progenitor…
